- AI has to serve humanity, humans must control it
- 5G goes global: Jio, T-Mobile achieve roaming first
- Growth is not enough, it must create better jobs: CEA
- Women seek more frontline jobs, but employers lag
- Microsoft deepens India AI play with Hyderabad cloud region
- Cooler oil, softer yields put bulls back in charge
- Lara Dutta says to ‘start a conversation’ in the fight against Alzheimer
- Pollution-proof your hair: Everyday care tips for urban lifestyles
Apollo hospitals expert urges communities to look beyond normal ageing
In Short
On World Alzheimer’s Day, senior neurologist Dr. Bindu Menon highlights how biological diagnosis and blood-based biomarkers are opening a new era in treating progressive memory loss and slowing disease progression.
Share :
Apollo hospitals expert urges communities to look beyond normal ageing
Nellore: As World Alzheimer’s Day is observed on September 21, experts emphasize that progressive memory loss should never be dismissed as normal ageing.
Senior Neurologist Prof Dr Bindu Menon from Apollo Hospitals, Nellore, notes that Alzheimer’s treatment has entered a new era of biological diagnosis and blood-based biomarkers that can slow disease progression.
Emphasizing that a diagnosis is a window of opportunity rather than a verdict, medical professionals urge society to replace stigma with early action, ensuring timely interventions that preserve patient independence, dignity, and personal relationships.
